Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme

Diğer sürümleri göster (1)

Aim: Effective type 2 diabetes management requires a multifactorial approach extending beyond glycaemic control. Clinical practice guidelines suggest targets for HbA1c, blood pressure and lipids, and emphasize weight reduction and avoiding hypoglycaemia. The phase 3 clinical trial programme for lira...

Detaylı Bibliyografya
Asıl Yazarlar:	Zinman, B, Schmidt, W, Moses, A, Lund, N, Gough, S
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2012

Benzer Materyaller

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.
Yazar:: Zinman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
Yazar:: Schmidt, W, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c)
Yazar:: Gough, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Achieving glycaemic control and weight loss with incretin-based therapies: a comparison of liraglutide, exenatide, and sitagliptin
Yazar:: Zinman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
Yazar:: Rosalie Koot, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

Reductions in HbA(1c) and the incidence of hypoglycaemic episodes are not affected by renal impairment in patients with type 2 diabetes treated with liraglutide
Yazar:: Gough, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies
Yazar:: Zinman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Liraglutide: from clinical trials to clinical practice.
Yazar:: Gough, S
Baskı/Yayın Bilgisi: (2012)

Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA1c and glucose‐lowering drug use before and after hypoglycaemia
Yazar:: Mads Bisgaard Bengtsen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Diagnosis of diabetes: HbA1c versus WHO criteria
Yazar:: Manley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Fructosamine and HbA1c
Yazar:: Kurumbian Chandran, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Hypoglycaemia in clinical diabetes /
Yazar:: Frier, Brian M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Understanding the relationship between the frequency of HbA1c monitoring, HbA1c changes over time, and the achievement of targets: a retrospective cohort study
Yazar:: Elton Mukonda, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.
Yazar:: Manuel Jonas Richter, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

How should HbA(1c) be incorporated into the diagnostic pathway for diabetes mellitus?
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

HbA1C and diabetes – an overview
Yazar:: S Pathmanathan, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.
Yazar:: Marcus Lind, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

High-performance liquid chromatography local reference ranges of hemoglobin fractions (HbA, HbA2, and HbF) in detection of hemoglobinopathies in western Kenya
Yazar:: Benard Mutua, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Could HbA(1c) have a role in the diagnosis of type 2 diabetes?
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Cyclical variation in HbA1c values during the year: clinical and research implications.
Yazar:: Hill, N, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Assessing the Clinical Utility of Point of Care HbA1c in the Ophthalmology Outpatient Setting
Yazar:: Mamtora S, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
Yazar:: Xiaojing Feng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements.
Yazar:: Nasir, N.M., ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Use of HbA1c in the diagnosis of diabetes.
Yazar:: Farmer, A
Baskı/Yayın Bilgisi: (2012)

Effects of thyroid status on HbA1c
Yazar:: Sivaranjani Ambalavanan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Drugs affecting HbA1c levels
Yazar:: Ranjit Unnikrishnan, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Current Status of HbA1c Biosensors
Yazar:: Hua Lin, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
Yazar:: Susanne Amsberg, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

The Influence of HbA1c and Gestational Weight Gain on Pregnancy Outcomes in Pregnant Women With Gestational Diabetes Mellitus
Yazar:: Qiuhong Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Haemoglobin types and variant interference with HbA1c and its association with uncontrolled HbA1c in type 2 diabetes mellitus
Yazar:: Joseph Malaba, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Symposium 3: HbA1c: Are HbA1c determinations reliable enough today in Argentina to adopt them as diagnostic criteria?
Yazar:: Carla Lucarelli
Baskı/Yayın Bilgisi: (2022-09-01)

Very low HbA1C, is it a problem?
Yazar:: Beuy Joob, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Significantly High HbA1c in Diabetic Patient with Hb J: Case Report
Yazar:: Wan Nor Fazila Hafizan Wan Nik, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Differential thermal stability and oxidative vulnerability of the hemoglobin variants, HbA2 and HbE.
Yazar:: Abhijit Chakrabarti, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Long-term sustained glycaemic control with liraglutide and glimepiride (both plus metformin), with added benefits of weight loss and less hypoglycaemia with liraglutide: 2-year LEAD-2 data
Yazar:: Frid, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Low HbA2 Level in β-Thalassemia Trait
Yazar:: Şinasi Özsoylu
Baskı/Yayın Bilgisi: (2013-03-01)

Engineering of the endogenous HBD promoter increases HbA2
Yazar:: Mandy Y Boontanrart, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Symposium 5: HbA1c: Infection management
Yazar:: Marcia Querci
Baskı/Yayın Bilgisi: (2022-09-01)

HbA2 measurements in β-thalassemia and in other conditions
Yazar:: Giovanni Ivaldi, ve diğerleri
Baskı/Yayın Bilgisi: (2014-09-01)

The clinical value of HbA1c in combination with FPG in the early screening of the elderly with type 2 diabetes
Yazar:: Liu Lihua, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)